Sun Pharmaceuticals, a major pharmaceutical firm, reported that it had taken fast action to limit the threat posed by the IT security incident and to control and remediate its effects. It also said that extra steps had been taken to guarantee the integrity of its system infrastructure and data.

The firm added that a ransomware group had taken ownership of the event.

The drug giant reported an information security incident at the business on March 2 and said it is looking into the situation. The company from Mumbai said that the harmed IT assets have been isolated.

This is to advise you that the company has experienced an information security event, and the company has isolated the impacted IT assets.

Additionally, it had stated that the event had no effect on the business's essential operations and processes.

The issue involved a breach of some file systems, the theft of some company data, and the loss of some individual data, the company said in an update on the situation.

As a result, we anticipate that revenues in several of our businesses may decline. It was stated that the event and remediation will cost the company money.

The statement went on to say that they are currently unable to determine any additional negative effects of the incident, including but not limited to additional information security incidents, higher insurance maintenance costs, the loss of management and employee time, or the potential for legal action.

On March 24, the firm announced that it would buy 60 percent of Vivaldis Health & Foods from its current owners for 143.30 crore, with the remaining 40 percent to be purchased in the future under specific terms and conditions.

As part of its containment measures, it said, “we proactively isolated our network and initiated the recovery process. As a result of these measures, the business operations have been impacted."